Natalizumab Elan Pharma
Negara: Uni Eropa
Bahasa: Inggris
Sumber: EMA (European Medicines Agency)
Laporan Penilaian publik
(PAR)
25-01-2008
Beberapa dokumen untuk produk ini saat ini tidak tersedia, Anda dapat mengirim permintaan ke layanan pelanggan kami dan kami akan memberi tahu Anda segera setelah kami bisa mendapatkannya.
Kirim permintaan.
Kirim permintaan.
Bahan aktif:
natalizumab
Tersedia dari:
Elan Pharma International Ltd.
Kode ATC:
L03AD
INN (Nama Internasional):
natalizumab
Kelompok Terapi:
Immunostimulants,
Area terapi:
Crohn Disease
Indikasi Terapi:
Treatment of moderately to severely active Crohn's disease for the reduction of signs and symptoms, and the induction and maintenance of sustained response and remission, in patients who have not responded despite a full and adequate course of therapy with a corticosteroid and an immunosuppressant; or are intolerant to or have medical contraindications to such therapies.
Status otorisasi:
Refused
